AbbVie (NYSE:ABBV) reported quarterly earnings of $2.97 per share which missed the analyst consensus estimate of $3.23 by 7.94 percent. This is a 12.08 percent increase over earnings of $2.65 per share from the same period last year. The company reported quarterly sales of $15.423 billion which beat the analyst consensus estimate of $14.977 billion by 2.98 percent. This is a 6.65 percent increase over sales of $14.462 billion the same period last year.